Phase 2 Immunity Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

Improving Vaccine Protection for Older Adults

Healthy AdultImmune System Responses and Trained Immunity After AS01 Administration

Singapore General Hospital40 enrolled1 locationNCT07527247

Recruiting

Phase 2

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Acute Lung Injury(ALI)Natural Killer Cell Mediated ImmunityPrimary Graft Dysfunction+1 more

University of California, San Francisco120 enrolled1 locationNCT06853223

Recruiting

Phase 2

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Inborn Errors of Immunity

Federal Research Institute of Pediatric Hematology, Oncology and Immunology100 enrolled1 locationNCT06199427

Recruiting

Phase 2

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Radiofrequency AblationTumor ImmunityImmunosuppression

Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT04150744